ARESTIN’s 25-Year Milestone Highlights Bausch Health’s Leadership in Periodontal Care
Market Chameleon (Thu, 19-Feb 9:19 AM)
Bausch Health’s RED-C Phase 3 Trials Miss Primary Endpoint—What Does This Mean for Rifaximin in Cirrhosis Care?
Market Chameleon (Fri, 23-Jan 8:09 AM)
